| Logo | Name | Σ | Employees |
|---|---|---|---|
 | Molecular Partners Pioneering DARPin Therapeutics for Patients Molecular Partners AG is a clinical-stage biotech company pioneering the design and development of DARPin therapeutics, a new class of custom-built drugs for medical challenges other modalities cannot readily address. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. Molecular Partners leverages the advantages of DARPins to provide unique solutions to patients through its proprietary programs as well as through partnerships with leading pharmaceutical companies. Molecular Partners was founded in 2004 and has offices in both Zürich, Switzerland and Concord, MA, USA. DARPins, Oncology, Immuno-Oncology, Radiopharmaceuticals, … 82 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 178 |
 |  Physiogenex Leading preclinical CRO specializing in metabolic disorders. Physiogenex is a leading preclinical research organization (CRO) specializing in metabolic disorders such as diabetes, insulin resistance, obesity, fatty liver (NASH / NAFLD), dyslipidemia, atherosclerosis and cardiovascular complications. We provide: - Classical and proprietary diet-induced in vivo models - Innovative in-house techniques (RCT) and gold standard methods (glucose clamps with radiolabelled tracers, ...) - In vivo preclinical imaging services Our models and technologies are customized and we deliver unparalleled scientific expertise for R&D, preclinical development, post-marketing studies and drug repositioning. We provide both the biopharmaceutical and nutraceutical companies with optimal and reliable solutions … 63 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 23 |
 | Fresenius Kabi France FreSenius Kabi is a global health company specializing in drugs and vital medical devices in infusion, transfusion and clinical nutrition. Fresenius kabi's drugs, technologies and services are used to help treat patients in emergency situations or with chronic diseases. The FreSenius Kabi product portfolio includes a full range of generic drugs administered intravenously, infusion therapies, clinical nutrition products as well as the medical devices necessary for the administration of these products. In the field of biosimilars, we focus on autoimmune diseases and oncology. In 2019, the first biosimilar product of Fresenius Kabi was launched. In the field of transfusion medicine … Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 15 | 464 |
 | Texcell Expert in viral safety since 1987. Texcell is a dedicated partner for biotechnology and pharmaceutical companies since more than 2 decades. Thanks to an unique combination of expertise in Virology and Immunology, we can provide a full support to your product development from the proof of concept to clinical studies and GMP manufacturing. Our state-of the Art facilities are located in France, Germany and in the US where we use most recent technologies to efficiently perform a wide range of assays What do we provide ? A specialized analytical lab for your preclinical and clinical studies, including: - Cell based … 11 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 8 | 110 |
 | BIOSYNEX PHARMA Because it all starts with the right diagnosis Biosynex designs, manufactures and markets rapid diagnostic solutions for accessible, preventive and personalized health. The group also develops brands with high notoriety in the world of well-being and health, such as Innoxa, an expert in ocular and dermo-cosmetic care, and parakito, specialist in anti-noisible solutions. Founded in 2005, the group sells its products and solutions in France and in more than 90 countries worldwide. Over the Counter (OTC) Diagnosis Products and Pharmacy | 3 | 232 |
 | Nor-Feed Botanicals for animal nutrition and health Since 2003, Nor-Feed invents, manufactures and markets natural plant extracts for animal nutrition and health. We are focused on a short product portfolio; our products are standardized, documented and efficient, with sustainable development principles. Nor-Feed provides its clients technical, marketing and regulatory support. Animal nutrition, Plants and plant extracts, Livestock Feed, Animal Health, Botanicals, and Feed 31 similar entities Type: SMB Activities: biotech deeptech Technologies: Bio sourced materials | 8 | 64 |
 | CosmAct, SAS Live Your Dream... COSMACT is a flexible and fast acting company supporting the raw materials, ingredients and cosmetic products manufacturers in the various steps of their Growth development. To achieve these goals, COSMACT is and will remain a light structure, in order to afford the reactivity and flexibility needed to set up case-by-case approaches that are needed oftenly in the cosmetic world. > Partnerships in the key cosmetic areas: Based in Paris area, COSMACT has set up several collaborations with raw material and ingredients manufacturers as well as experts chosen for their background, their expertise and their efficiency in the … Type: SMB Activities: biotech deeptech manufacturing cosmetics Technologies: New Materials | 2 | 8 |
 | KARETIS New generation consulting for a changing world KARETIS is an innovative business services company providing advisory support and solutions to help organizations excel and grow. With offices in Paris, Lyon and Singapore, we are a team of scientists, engineers and business experts applying a scientific approach and advanced technologies to Marketing, Sales and Human Resources across Commercial Strategy, Organization Design and Customer Excellence. Visit our website, read our posts, feel free to contact us anytime and anywhere! We will be happy to meet you and see how we can help. Pharmaceuticals, Healthcare and Life Sciences, Commercial Strategy, Customer Excellence, Organisation … 25 similar entities Type: SMB Activities: biotech consulting deeptech Technologies: Data Analytics | 42 | 17 |
 | Ophtalmic Compagnie Your partner for sight since 1986 A partner in the view of the French since 1986, Ophtalmic Compagnie is an independent laboratory with nearly 170 employees. The company achieves 45 million euros in turnover in the design and distribution of corrective and cosmetic contact lenses, cleaning solutions for lenses, food supplements for visual health but also ophthalmic glasses. This is subdivided into 5 very distinct activity centers: -Ophtalmic contactology (contactology products, lenses and solutions) -Ophtalmic vision (corrective and frame glasses) -Phthalmic health (micro nutrition products for ocular health) -Ophtalmic services (multi -brand distribution of contact lenses and maintenance solutions) - … | 3 | 105 |
 | Cellnovo Group The first connected diabetes management platform. Cellnovo is an innovative medical technology company specialising in diabetes. The company develops and markets The Cellnovo System, the world's first mobile, connected, all-in-one diabetes management system that helps make life easier for people with type 1 diabetes. Compact, intuitive and entirely connected, Cellnovo’s micro-pump for insulin delivery communicates wirelessly with a locked-down Android phone, offering the quality and responsiveness that is to be expected from consumer-grade smartphones, while preserving the high-level of security of a medical-grade device. This unique device allows optimal management of diabetes whilst ensuring extensive freedom of movement and peace … Type: SMB Activities: deeptech biotech healthtech Technologies: IoT | 3 | 15 |
 |  Medincell Better Medicine For All Better Medicine for All MedinCell is a pharmaceutical company at commercial stage. We develop a portfolio of long-acting injectables in various therapeutic areas. Our proprietary technology BEPO® aims to ensure patient compliance, improve the effectiveness and accessibility of treatments, and reduce their environmental footprint. We collaborate with tier-one pharmaceutical companies and foundations to improve Global Health through new therapeutic options. Our mission is to contribute to the improvement and protection of the health of populations across the world. The fair sharing of the value created with all our employees is the foundation of our business model. … 73 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 20 | 153 |
 | Fluigent Smart Microfluidics Fluigent develops, manufactures and commercializes innovative fluid handling solutions for a variety of rapidly growing applications where fluid control is critical. We have delivered microfluidic solutions to hundreds of customers worldwide since 2006. We offer to our customers a full range of engineering services and technical assistance to design and optimize their set-ups. Our solutions are modularized, enabling our customers to save precious time with cumbersome engineering fluidic developments (such as re-designing and re-developing electronic and software interfaces for each new set-up). Quality is at the center of all our activities. Our Customers can benefit from our ISO-9001 … | 15 | 48 |
 | METabolic EXplorer Alternative NOW Contributing to the necessary ecological transition by innovating to produce and market otherwise low carbon functional ingredients which enter into the manufacture of consumer products is the raison d'être of Metabolic Explorer (Metex). From renewable raw materials, the group develops and industrializes innovative and competitive industrial fermentation processes as an alternative to petrochemical processes to meet new societal expectations of consumers and energy transition issues. Its two industrial units, Metex Nøvistago (based in Amiens) and Metex Nøvista (based in Carling St-Avold), allow the group to concretize its ambition to become one of the leaders in the world market … Type: SMB Activities: biotech deeptech Technologies: Bio sourced materials | 6 | 29 |
 | HUMEAU Laboratory expert Trade company on the sale of laboratory equipment, consumables and analysis products. As a major actor in the distribution of laboratory equipment, Humeau offers a wide choice of products with 50,000 articles referenced and more than 500 suppliers and partners. In order to provide you with a quality and personalized service, Humeau has a sales force of 10 salesperson and homeless technico-commercial, a customer support service made up of 8 sedentary technico-commercial and a after-sales service of 6 technicians. HUMEAU (LABORATORIES HUMEAU) was created in 1938 and manufactured ingredients (ferments and premises) for dairy and cheese industries. It … | 6 | 67 |
 | Microsynbiotix, Ltd. A Sundew company We are creating a potentially revolutionary algal platform technology. Thanks to major advances in algal genomics and molecular biology, microalgae can be engineered to express inexpensive therapeutic proteins and vaccines of economic value. The cost of the synthetic biology tools has dropped. We are building our technology based on solid, peer-reviewed science[1][2][3][4]. By using microalgae as an oral delivery vehicle, we can substantially cut the labor and post-processing production costs, allowing us to produce effective vaccines that are much more affordable and user-friendly. Our technology can reduce or eliminate the use of antibiotics, reduce fish mortality rates … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 3 | 50 |
 | Glossier, Inc. Changing how the world sees beauty. Here at Glossier, beauty is about you. From our formulas to packaging, playful shades to seriously-great skincare—Glossier was built to make beauty accessible and uncomplicated. Before we launched Glossier in 2014, we started as Into The Gloss. A beauty website and community devoted to sharing real information with real people, about really amazing products. It’s where we realized that beauty shouldn’t be built in a boardroom—it should be built by you. This ethos gave birth to our philosophy: Skin First. Makeup SecondTM. We prioritize skincare because we believe that healthy skin is the best … Type: Startup Activities: biotech deeptech e-commerce cosmetics Technologies: Bio sourced materials | 25 | 577 |
 | Mursla Bio Unlocking organ-specific intelligence in blood for cancer detection Mursla Bio is a pioneering biotech company on a mission to transform cancer care by pushing the boundaries of biopsy technology. Its breakthrough Dynamic Biopsy platform combines the data richness of tissue biopsy with the convenience of liquid biopsy. Dynamic Biopsy is made possible by coupling the latest of extracellular vesicle (EV) and extracellular omics science with Mursla Bio’s pioneering EV technologies. Mursla Bio’s initial focus is to transform the surveillance of liver cancer in high-risk populations - the fastest growing cause of cancer related deaths. Mursla Bio is currently conducting a … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 15 |
 | SmartTRAK Smart Data. Smart Decisions. Smart Business. SmartTRAK is a leading provider of online business intelligence and dynamic decision-making tools specifically for life sciences product management professionals. SmartTRAK provides insight including market share data and competitive developments impacting the orthopedic, wound care and neuro therapies markets. SmartTRAK’s Brain Trust is comprised of marketing, corporate development, R&D, and competitive intelligence professionals from major medical device corporations including Medtronic, J&J, Stryker and 3M, among others. SmartTRAK MODULES ORTHOPEDICS • OrthoBiologics (Bone, Cartilage, Dics, Joint Fluid, Meniscus, Soft Tissue Replacement) • Extremities (Foot & Ankle, Wrist & Hand, Shoulder) • Spine (Fusion, Motion, Spinous … Type: Startup Activities: healthtech martech biotech deeptech Technologies: Data Analytics | 2 | 34 |
 | CITO Medical New Product Development of Medical Devices & Biotech Instruments CITO Medical is an engineering firm specializing in new product development of medical devices, life science lab equipment, point of care diagnostic instruments and microfluidic cartridges. CITO partners with technology startups, Fortune 500 companies and academic institutions to bring product and research ideas to life through precision engineering, innovative hardware and solution-driven design and development. A unique blend of engineering principles and modern design techniques enable our engineers to turn your ideas into working products and solutions that transform everyday life around the world. Core capabilities include: Mechanical Engineering, Electrical Engineering, … 60 similar entities Type: Startup Activities: healthtech manufacturing deeptech biotech Technologies: Synthetic Biology | 0 | 14 |
 | Benchling Biotechnology is rewriting life as we know it, from the medicines we take, to the crops we grow, the materials we wear, and the household goods that we rely on every day. But moving at the new speed of science requires better technology. Benchling’s mission is to unlock the power of biotechnology. The world’s most innovative biotech companies use Benchling’s R&D Cloud to power the development of breakthrough products and accelerate time to milestone and market. Come help us bring modern software to modern science. https://www.benchling.com/careers/ 7 similar entities Type: Startup Activities: biotech deeptech it services Technologies: SaaS | 35 | 780 |
 |  Cogentis Therapeutics, Inc. Developing first in class therapies for the treatment of dementia. Cogentis Therapeutics is an early stage biotechnology company with a mission to develop and commercialize an innovative disease-modifying therapeutic for dementias such as frontotemporal dementia (FTD) and Alzheimer’s disease (AD) to improve patients’ quality of life and reduce the burden of disease on their families, providers, and the overall healthcare system. Our immediate goal is to develop a peptide-based compound, CT-526, for FTD. neurodegeneration, neuropeptide, frontotemporal dementia, Alzheimer's disease, and progressive supranuclear palsy 33 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 7 |
 | Halo Neuroscience Creators of Halo Sport, the brain stimulator that helps you develop muscle memory faster. Welcome to Halo Neuroscience's home on LinkedIn. Please follow us to learn more about how the brain impacts human performance. Below you can read more information about our company. You can also send us an email at hello@haloneuro.com, or see our available job postings at haloneuro.com/careers. ––––––– Halo Neuroscience is a neurotechnology company focused on human performance. Our first product, Halo Sport, utilizes neuropriming technology to accelerate the neurologic gains of strength and skill learning that result from athletic training. Since coming out of stealth in … Type: Startup Activities: biotech deeptech healthtech | 2 | 8 |
 | Thync Global, Inc. Neurostimulation for everyone Thync was founded in 2011 with the vision of revolutionizing brain health and performance through personal technologies that interact directly with the brain and nervous system. The company has developed multiple products that modulate mood and reduce stress. 5+ years of research and five thousand testing sessions from Thync’s team of neuroscientists and engineers led to the creation of Feelzing: the world’s first, easy-to-use neurostimulation patch to improve focus and energy. Consumer Electronics, Wearable Technologies, Neuroscience, and Neurobiology 6 similar entities Type: Startup Activities: biotech consumer goods deeptech | 1 | 1 |
 | OpenBCI We make open-source tools for neuroscience & biosensing OpenBCI stands for open-source brain-computer interface (BCI). Anyone with a computer can use OpenBCI tools to sample physiological data from their body. For over a decade, OpenBCI has led the world in developing hardware and software for accessible neurotechnology. Galea, OpenBCI’s latest product, is an enterprise, multi-modal biosensing headset designed to interface with the human mind. It combines high-fidelity AR/VR/XR display technology with the most comprehensive bio-sensing headwear ever made commercially available. Novel BCI hardware and artificial intelligence are key to OpenBCI's effort to turn the ocean of human physiological data into … 2 similar entities Type: Startup Activities: biotech deeptech Technologies: 3D Printing Affective Computing | 15 | 24 |
 | Allogene Therapeutics Allogene Therapeutics, with headquarters in South San Francisco, is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR TTM) products for cancer and autoimmune disease. For additional information on our guidelines, please visit www.allogene.com/news-center#community-guidelines Please be aware that the FBI recently issued a warning about an increased number of fake job postings for remote work employment that target applicants' personally identifiable information. All approved Allogene Therapeutics positions are accessible via the Allogene Careers page at www.allogene.com/careers. oncology, cancer, biotechnology, immunotherapy, CAR T, and autoimmune 12 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 6 | 276 |
 | SOMAVAC® Medical Solutions, Inc. Pioneering SOMAVAC® Deep Tissue Negative Pressure Therapy. SOMAVAC® Medical Solutions, Inc. is a MedTech company developing negative pressure therapy solutions for breast cancer recovery. Our platforms are led by our patented SOMAVAC® Deep Tissue Negative Pressure Therapy which is the first powered negative pressure therapy device cleared for seroma prophylaxis. For patients undergoing breast reconstruction and/or mastectomies, negative pressure delivered by SOMAVAC® removes fluid as it is produced, obliterates dead space, and holds tissues together which have been shown to prevent seromas. Seromas can lead to surgical complications like surgical site infections, wound dehiscence, etc. SOMAVAC® is FDA cleared for … Type: Startup Activities: deeptech healthtech biotech Technologies: Synthetic Biology | 0 | 9 |
 | IBT-Bioservices Accelerating research & development Integrated BioTherapeutics LLC (IBT Bioservices) is a contract research organization (CRO) offering in vitro and in vivo services as well as products to support your biomedical research and development needs. Whether you are a biotech startup or an established pharmaceutical company, IBT serves as your trusted partner, simplifying the development process and accelerating your journey toward bringing innovative biotherapeutics to patients in need. The team of highly skilled scientists, researchers, and industry experts at IBT work collaboratively to deliver exceptional results and accelerate the development process for its clients. By offering comprehensive services and concierge-level support … 2 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 11 |
 | Neopharm Boston CRO with extensive expertise in small molecule chromatography and purification We are Neopharm Boston Inc., formerly Averica Discovery Services, a Contract Research Organization (CRO) recognized by our proficiency in small molecule analysis and purification. Our enduring legacy of excellence positions us as a strategic partner within the pharmaceutical industry. Our recent expansion has equipped us to deliver a comprehensive, fully integrated array of services, facilitating a seamless journey from development and preclinical stage to commercial launch. At Neopharm Boston, our remarkable high throughput capabilities extend beyond advanced instrumentation to encompass a highly skilled and capable team. This synergy enables us … 62 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 3 | 163 |
 | OneSkin Science-based solutions designed to maximize your healthspan. OneSkin is a longevity company on a mission to transform the way we think about skin and aging. Founded by a team of four female PhDs, OneSkin’s products focus on skin longevity. OneSkin’s proprietary peptide, OS-01, is the first ingredient designed to reduce skin's biological age by improving skin barrier, supporting DNA damage repair, and preventing the accumulation of aged cells. Data-driven Science , Human 3D Skin Models, and Genomics Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 44 |
 | Syapse Syapse is a RWE company dedicated to extinguishing the fear and burden of serious disease by advancing real-world care. To achieve more precise care for every patient, we need to transform real-world evidence into insights that can directly impact care. At Syapse, that is real-world care. It’s found in the way we empower healthcare organizations to work together in active, transparent partnerships, delivering complete patient insights to answer the questions that matter and then purposefully applying it at where patients receive care – driving real impact for cancer patients and beyond. bioinformatics, collaboration, cloud computing, big data, genomics, omics, health … 65 similar entities Type: Startup Activities: it services biotech deeptech healthtech Technologies: Data Analytics | 13 | 54 |
 | Click Therapeutics, Inc. Click Therapeutics, Inc., develops, validates, and commercializes software as prescription medical treatments for people with unmet medical needs. As a leading innovator of Digital TherapeuticsTM, we deliver accessible, clinically proven, FDA-regulated prescription treatments to the smartphone in your hand. Our treatments are defined by our commitment to applying technical and scientific rigor and patient-centric design to the development process. This results in uniquely engaging experiences that achieve compelling clinical outcomes for patients seeking new treatment options. We are continuously expanding and refining our shared platform technologies with novel cognitive, behavioral and neuromodulatory mechanisms of action and advanced data-driven tools such … 5 similar entities Type: Startup Activities: deeptech biotech healthtech Technologies: A.I. - Machine Learning | 12 | 181 |
 | BIOREALIZE Biorealize is the leading biodesign store. Join us! | 2 | 2 |
 | Likarda Improving the Efficacy of Cellular Therapies Likarda is a biotech company developing enabling technologies to transform the way cell therapies are delivered and optimized. Our revolutionary method to coat cells with stealth hydrogels, called Core Shell Spherification® (CSS), protects cells from destruction, keeping them viable while maintaining them in the intended location within the body. Unlike our competitors, Likarda has developed a library of over 50 different hydrogel formulations that work with Core Shell Spherification®, resulting in the ability to uniquely tailor the coating molecules to the specific requirements of the therapeutic cells themselves. From durable and long-term coatings to … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 14 |
 | VRG Therapeutics Regional leader in preclinical R&D with a world-class protein evolution tech platform for CGT applications Our mission is to cure diseases via targets and MoAs that cannot be reached with traditional approaches. Leveraging our unique platform, we optimize peptides/proteins of natural origin using directed evolution to create cutting-edge CGT products or peptide-based pharmaceuticals. VRGT’s management and staff members were selected based on their international research experience and outstanding pharma industry achievements. Our people have outstanding professional expertise in preclinical/clinical R&D and scientific project management, pharmacology, business development and medical marketing. For years, they have worked in the most prestigious academic … 158 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 26 |
 | AnimalBiome Since 2016, AnimalBiome has helped tens of thousands of pet parents and veterinarians monitor and improve pet gut health Since 2016, AnimalBiome has helped tens of thousands of pet parents and veterinarians monitor and improve the gut health, and overall health, of companion animals around the world. See how we can help your pet or veterinary practice at animalbiome.com or animalbiome.vet (veterinarians only). Microbiome assessment, Microbial biomarkers for chronic health conditions, Fecal transplant pills for pets, Personalized medicine for pets, Cat health, Dog health, and Pet service | 0 | 50 |
 |  Epizyme On August 12, 2022, Epizyme was acquired by Ipsen, expanding Ipsen’s oncology portfolio. Epizyme now operates as an Ipsen company with a shared goal of delivering innovative treatment options to underserved patients. Ipsen is a global specialty-driven biopharmaceutical group focused on innovation and Specialty Care. It develops and commercializes innovative medicines in three key therapeutic areas - Oncology, Neuroscience and Rare Disease. Its commitment to oncology is exemplified through its growing portfolio of key therapies for prostate cancer, neuroendocrine tumors, renal cell carcinoma and pancreatic cancer. Neuroscience is advancing at an unprecedented rate and Ipsen is at the forefront of … 10 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 5 | 99 |
 | Neurotrack We partner with healthcare providers and payers to optimize cognitive screening workflows with efficient digital tools. Cognitive health starts here. Neurotrack’s rapid digital cognitive screening can identify patients with cognitive impairment in just 3 minutes. This tool enables clinicians—for the first time ever—to screen and monitor cognitive function as they would any other vital sign. We believe it will increase the number of annual cognitive assessments completed, open the door to meaningful early intervention, improve access to new pharmaceutical treatment options, and validate or alleviate patient concerns. By design, it fits easily within a typical primary care annual wellness visit … Type: Startup Activities: biotech deeptech Technologies: SaaS | 9 | 38 |
 | WEKA The Data Platform for AI & Performance-Intensive Workloads WEKA helps data-driven organizations seamlessly and sustainably store, process, and manage data virtually anywhere with cloud simplicity and on-prem performance. Our software-defined, cloud-native data platform turns stagnant data silos into streaming data pipelines that fuel next-generation workloads like AI and HPC. High-Performance Computing, Machine Learning, Analytics, Genomics, Artificial Intelligence, Data Management, Data Pipelines, Data Acceleration, Hybrid Cloud, Data Platform, Storage Software, Containers, Cloud, Multicloud, Generative AI, Cloud Storage, and GPU Acceleration 68 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Machine Learning Data Analytics SaaS Generative A.I. | 24 | 519 |
 | Optinose As of May 21, 2025, Optinose was acquired by Paratek Pharmaceuticals. Please follow @Paratek for the latest updates and information about the acquisition. Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 0 | 149 |
 | Venatorx Pharmaceuticals, Inc. Discovering & developing novel anti-infectives to treat multi-drug resistant bacterial & hard-to-treat viral infections. Venatorx Pharmaceuticals is a private pharmaceutical company that is focused on the discovery and development of novel anti-infectives to treat multi-drug-resistant (MDR) bacterial infections and hard-to-treat viral infections. antibiotics, antiinfectives, antivirals, drug development, drug discovery, pharmaceuticals, #battlesuperbugs, #WorkingToFightAMR, clinical, research, #squashsuperbugs, biotech, and antimicrobialresistance 81 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 75 |
 | Envisagenics Artificial Intelligence, High Performance Computing, and RNA sequencing data to find cures faster than ever before. Envisagenics was founded in 2014 as a spinout of Cold Spring Harbor Laboratory. Our mission is to reduce the complexity of biomedical data to accelerate the development of innovative therapeutic solutions through RNA splicing analytics and artificial intelligence. We focus on the discovery of RNA therapeutics. Over 30 million people in the US suffer from genetic diseases or cancer that could be caused by mutations affecting RNA splicing. 370 human diseases are known to be caused by splicing errors, and more remain to be … Type: Startup Activities: biotech deeptech Technologies: A.I. - Deep Learning A.I. A.I. - Machine Learning | 17 | 49 |
 | Medicenna Therapeutics Corp. Evolutionary Cytokines | Revolutionary Medicines | TSX: MDNA | OTCQX: MDNAF Medicenna is a clinical stage immunotherapy company focused on the development of novel, highly selective versions of IL-2, IL-4 and IL-13 Superkines and first in class Empowered Superkines. Medicenna's long-acting IL-2 Superkine, MDNA11, is a next-generation IL-2 with superior CD122 binding without CD25 affinity thereby preferentially stimulating cancer killing effector T cells and NK cells. Medicenna’s early-stage BiSKITsTM program, (Bifunctional SuperKine ImmunoTherapies) is designed to enhance the ability of Superkines to treat immunologically “cold” tumors. Medicenna's IL-4 Empowered Superkine, MDNA55, has been studied in 5 clinical trials including a … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 2 | 25 |
 | Revvity Signals Revvity Signals Software has more than three decades providing unrivaled support for scientific workflows. Our powerful solutions are used across R&D disciplines from drug discovery to specialty chemicals material development. Now under our comprehensive Signals Research Suite, our end-to-end SaaS solution integrates workflows across biology, chemistry and materials new product development to accelerate scientific innovation, and help scientists help each other. In addition, our robust solution, powered by Spotfire®, can revolutionize the clinical trial process. From our internationally recognized flagship ChemDraw® and E-Notebook applications, to our Signals Research Suite to our exclusive Spotfire® partnership that brings scientific data analytics to … Type: Startup Activities: deeptech biotech Technologies: Data Analytics | 20 | 396 |
 | mimiX Biotherapeutics Next Generation Biofabrication - Sound Induced Morphogenesis //Acoustic biofabrication MimiX biotherapeutics introduces Sound Induced Morphogenesis. We extend the boundaries of biofabrication, making bioengineered, artificial human organs and tissues a future reality. Sound Induced Morphogenesis (SIM) is a revolutionary approach in biofabrication. It mirrors nature’s design, to aggregate and pattern biologicals by tuning sound profiles under contactless, fast and delicate culture conditions resulting in a morphologically induced tissue generation. We introduce cymatiX®, a unique acoustic biofabrication solution that makes the Sound Induced Morphogenesis technology easily accessible to the scientific and clinical community Visit www.mimixbio.com to learn more. mimiX biotherapeutics is a … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 5 | 8 |
 | Bioptimus We build foundation models that will transform biology. We use cutting-edge technology to transform multiscale data into actionable representations to fuel breakthrough discoveries. Join us on our mission to build foundation models that transform biology. artificial intelligence, biology, and foundation models 58 similar entities Type: Startup Activities: biotech it services Technologies: Generative A.I. A.I. | 15 | 28 |
 | Cyprio Created in 2017, Cyprio is founded on ten years of research at the prestigious French institute for higher education in science and engineering, Ecole Supérieure de Physique et Chimie Industrielles de la ville de Paris (ESPCI Paris), with a strong expertise in the field of 3D cell culture, liver biology and drug development. This makes Cyprio the holder of a unique technology for fabrication of alginate liquid-core capsules containing 3D cellular models physiologically more relevant than traditional monolayer cell culture and compatible with high throughput screening applications. Our first product "HepatoPearl" has been validated as a beneficial in vitro liver … 11 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 2 |
 | Nosty Making Pharma democratic. Nosty is a decentralized platform where stakeholders in drug development work together to bring new therapeutics to patients faster and more efficiently than ever. The platform enables leading researchers and labs to raise fund among patients and the general public by turning IP and its development into a liquid and easily investable asset. The project is led by a team of serial entrepreneurs and professionals from the pharmaceutical industry, based in US and Europe. Type: Startup Activities: deeptech biotech Technologies: SaaS | 2 | 2 |
 | aKen Medical The Next-generation of personalized and adaptive radiotherapy. αKen Medical is a biotechnology company aiming to develop and bring to market the Next-generation of personalized and adaptive radiotherapy for treating solid cancer tumors. The proposed therapies seek to improve the effectiveness of alpha therapy and reduce its side effects. Radiotherapy, Cancer treatment, Brachytherapy, Targeted therapy, Biotechnology, Medical devices, Alphatherapy, Nanotechnology | 7 | 4 |
 | POLYVALAN Proteins Structures Got Easier With Crystallophores Emerged from academic research, POLYVALAN (IBS & ENS Lyon Spin-off company) is a young innovative company founded in December 2016 dedicated to structural biology. POLYVALAN competitive edge is its unique chemical approach allowing significant gain of effectiveness, time and/or precision for protein structure determination that allows an optimal use of the existing large equipments. structural biology, protein crystallization, crystallization screening, nucleating agent, phasing agent, crystallophore, structure determination, X-ray crystallography, and drug design 59 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 2 | 3 |
 | CTIBIOTECH Visionary science. CTIBiotech, models for your research. CTIBiotech uses advanced tissue engineering techniques (3D bioprinting, bioreactors) to develop models and bioassays needed to test the efficiency and effect of ingredients. Our models have varying levels of complexity suited our clients needs in the pharmaceutical industry and dermato-cosmetics sectors. We also work in partnership to co-develop new models that fit a specific requirement. The CTIBiotech Biobank is accredited by French authorities and we can offer human tissues, primary cells, cell lines and tumours. We currently store around 30 000 samples, from 0-94 years and from different ethnical backgrounds. Our customers come … 4 similar entities Type: Startup Activities: biotech deeptech Technologies: 3D Printing Synthetic Biology | 23 | 21 |
 | Orakl Oncology Biology x AI-powered drug development platform to transform precision oncology. Orakl Oncology leverages a unique collection of patient tumor avatars that combines biology and clinical data to fuel the therapeutic arsenal to fight cancer. With our platform we partner with oncology players to identify relevant targets and deliver new drugs, faster. 64 similar entities Type: Startup Activities: biotech deeptech Technologies: Data Analytics Synthetic Biology | 2 | 20 |
 | En Carta Diagnostics Diagnostics for better care, everywhere. Diagnostics for Better care, Everywhere. En Carta Diagnostics is a synthetic-biology biotech company leveraging patented technologies to decentralise highly reliable molecular diagnostic solutions. synthetic biology, cell-free, biotech, and molecular sensing 60 similar entities Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology | 5 | 11 |
 | BELAB R&D : Development of connected physiological analysis devices for sweat measurement and sports performances optimization Revolutionizing sports performance with cutting-edge biotech ! At BELAB, we are not just a biotech start-up. We are leading the future of sports performance and recovery through innovative, connected technologies. 🔬 BeOne : The first on-board physiological lab Our BeOne armband is a breakthrough in real-time sweat analysis, enabling athletes to measure, monitor, and optimize hydration and performance during training or competition. This connected device is a game-changer in personalized sports science and wearable technology. 📈 Enhance your performance. Personalize your hydration. Train smarter. With … | 4 | 14 |
 | Pasithea A New Approach to treat Sleep Apnea Pasithea: A New Approach to Sleep Apnea Pasithea introduces a novel and groundbreaking non-invasive adaptive neuromodulation approach to address respiratory disorders. The applied stimulation elicits a response from the autonomic nervous system in the early phases of apnea. Clinical studies have shown that Pasithea's therapy is safe and well-tolerated, and that it can significantly improve respiratory disorders. The therapy is also non-invasive, which means that it does not require surgery or hospitalization. Type: Startup Activities: deeptech healthtech biotech Technologies: Synthetic Biology | 1 | 4 |
 | TheraPPI Bioscience Targeting protein interactions for health Founded in 2023, TheraPPI Bioscience is a biotechnology company whose science originates from the CRCL (Centre de Recherche de Cancérologie de Lyon, France). We modify protein interactions to offer treatments where current therapies fail. Our approach represents a paradigm shift in tackling cancer resistance and non-curable rare diseases protein-protein interaction, PPI, small molecule, therapeutics, oncology, and rare disease 80 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 6 |
 | IMD-Pharma SAS Rebalancing the immune system, resolving inflammation. Drug candidates from our molecular platforms normalize the immune system by downregulating pro-inflammatory immune response and upregulating regulatory immune response. IMD-Pharma S.A.S is a french biotechnology company conducting research and development of innovative drug candidates for immune-related inflammatory diseases. Founded in 2016, IMD-Pharma is a company from the Laboratoire de Chimie de Coordination (CNRS) and the Centre de Physiopathologie de Toulouse Purpan (INSERM/CNRS/Université Toulouse III). immuno-modulation, anti-inflammatory drugs, chronic inflammatory diseases, Multiple Sclerosis, Rheumatoid Arthritis, dendrimers, monocyte rehabilitation, and psoriasis 49 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 7 |
 | 4Moving Biotech Restoring mobility for a better quality of life 4Moving Biotech is a clinical-stage biopharmaceutical company founded in 2020. We are committed to develop first-in-class breakthrough therapies for the millions of patients suffering from osteoarthritis (OA) in the world. 4Moving Biotech is a subsidiary of 4P-Pharma, an innovation accelerator biotech company. Osteoarthritis, DMOAD, Research and Development, and Biotechnology 31 similar entities Type: Startup Activities: deeptech biotech | 7 | 6 |
 | CERTIS Therapeutics Disruptive solutions for image guided therapies Certis Therapeutics develops and markets minimally invasive thermo-ablation solutions. These solutions are controlled by real time MRI images including accurate 3D temperature maps and deliver treatments for cardiological, oncological and neurological diseases. The company aims at providing best in class solutions delivering significantly higher efficacy and safety as to current standards of care. medical device, oncology, cardiology, MRI guided, and Thermal ablation 40 similar entities Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology | 3 | 13 |
 | RebrAIn ReBrain standardizes targeting for DBS and brain lesion surgeries in Parkinson and essential tremor diseases RebrAIn offers a precise targeting technology for Deep Brain Stimulation (DBS). This is achieved through an algorithm based on Artificial Intelligence and a collaborative health data registry. With this innovative technology, developed to effectively identify the areas of the brain to be treated, ReBrain simplifies and standardizes DBS by reducing the risks and making it less traumatic, thus allowing more patients worldwide to be treated. Type: Startup Activities: deeptech healthtech biotech Technologies: A.I. Data Analytics | 34 | 18 |
 | Corlieve Therapeutics At Corlieve, we are focused on bringing novel therapeutic options to patients with severe neurological disorders. Corlieve Therapeutics, a fully owned subsidiary of UniQure, is a biotechnology company focused on bringing novel therapeutic options to patients with severe neurological disorders. 60 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 2 | 1 |
 | ECONICK Vegetable biotechnology society producing eco -responsible metals from plants Bio-Sourced Strategic Metals beg & amp; Phytoremediation Services Econick, startup founded by researchers from Laboratories in the Grand Est, has developed an innovative process exploiting the potential of so -called hyperacumulative plants to extract certain metals from contaminated or naturally mineralized soils. 115 similar entities Type: Startup Activities: biotech deeptech greentech Technologies: Bio sourced materials | 1 | 6 |
 | MAAsiRNA MAAsiRNA develops a pioneering targeted therapy utilizing small interfering RNA (siRNA). A significant challenge in the field of nervous system pathologies lies in the absence of effective treatments. MAAsiRNA develops a pioneering targeted therapy utilizing small interfering RNA (siRNA). After over a decade of intensive interdisciplinary research, we have successfully developed a siRNA-based treatment for Charcot-Marie-Tooth disease type 1A (CMT1A), the most prevalent form of hereditary peripheral neuropathy. CMT1A affects 1 in 5000 people, comprising a total of 1.5 million individuals worldwide. Our current objective is to advance towards a patient-ready therapy. Our innovative therapeutic approach has the potential to … Type: Startup Activities: healthtech deeptech biotech Technologies: Synthetic Biology | 1 | 6 |
 | Blue Bees Therapeutics Blue Bees Therapeutics develops immunomodulatory proteins with therapeutic potential to fight cancer Blue Bees Therapeutics is a biotechnology company founded in March 2022, dedicated to the development of first-in-class immunotherapies for the treatment of cancers, based on a breakthrough technology discovered by the team led by Dr Michel Léonetti, within the Department of Pharmacology and Immunoanalysis from CEA Paris-Saclay. This technology allows to generate antibodies stimulating the anti-tumor immune response via a double cell receptor targeting coupled with heparan sulphate proteoglycans (HSPG). Immunothérapie, Immuno-oncologie, pharma, Biotech, Immunologie, Oncologie, Cancer, Médicament, and Drug 176 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 8 | 9 |
 | Deeptope Advanced Antibody Expertise Deeptope's expertise lies in antibody charaterisation (epitope/paratope mapping) and optimisation using high throughput methods. antibody, paratope mapping, epitope mapping, and antibody optimisation 77 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 2 | 7 |
 | Kimialys Innovative biosensing solutions for diagnostic and pharmaceutical companies, leveraging our K-One® surface chemistry. We are a team of chemists and biosensor engineers gathered around a common mission: shaping the future of biodetection for a better world. Kimialys is the result of 10 years of meticulous academic research in surface chemistry. Controlling what is happening on the surface is a fundamental aspect of biosensing techniques such as rapid tests, point-of-care diagnostics, and real-time sensors. Without the right surface interactions, even the most advanced biosensors can falter, leading to misleading results. Our research efforts have always been to optimize these crucial parameters, … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 16 | 20 |
 | AberActives SAS Bioraffinate seaweed for nutraceutical and cosmetics Aberactives is a marine biotechnology company Our laboratory is located on the Laber site in the premises of the Roscoff Marine Station, a global center of excellence in fundamental research on algae. The start-up offers the use of bacterial enzymes to transform algal sugars in the prospect of making ingredients in cosmetics and/or health nutrition. 4 similar entities Type: Startup Activities: biotech greentech manufacturing deeptech | 11 | 8 |
 | Sirius NeoSight New view for cancer Therapeutic Sirius Neosight is an innovative technological breakdown company which aims to become a key player in the detection of subclashed neo-cancers, relapses and therapeutic monitoring of patients thus offering a new look to doctors on the therapeutic efficiency implemented. Sirius Neosight operates a patented from a patented rupture technology from a consortium of academic laboratory experts in the field. 59 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 19 | 7 |
 | Laboratoire de Biologie Tissulaire et Ingénierie thérapeutique (LBTI) Explore Understand Innovate LBTI is a leading French research laboratory specializing in the study of healthy and diseased tissues and in the development of innovative therapeutic strategies with high potential for translation toward clinical applications. We have strong expertise in human skin, cartilage and mucosae. Our specific research aims are: > to analyze the basic mechanisms of tissue organization and homeostasis, and to identify potential therapeutic targets > to understand and model the tissue response to physiological or pathological stress (including mechanical stress and aging) > to develop novel therapeutic approaches for tissue repair and targeted delivery of therapeutic agents … 17 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 54 |
 | NERVOSAVE THERAPEUTICS Innovative therapies for peripheral nerve diseases Nervosave Therapeutics discovers and develops therapies that slow, stop and reverse a broad range of demyelinating peripheral nerve diseases. Our first aim is to develop best in class Gene Therapy for CMT1A patients and beyond for all demyelinating CMT diseases. We develop robust discovery programs targeting both CMT diseases and acquired demyelinating peripheral neuropathies such as diabetic peripheral neuropathy and Guillain-Barré syndrome. 9 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 4 |
 | Cell&Soft Soft culture plates for pleased cells Cell&Soft is a young french biotech located in the AURA region, in Grenoble city. Born from a joint project between LTM Lab (CNRS) and CEA BIG, Cell&Soft is specialized in the development, production and sale of soft and biomechanical substrates for in vitro cell culture. Cell&Soft offers solutions to enhance the physiology and the relevance of cell culture and cell-based assays. biotechnology, cell culture, soft substrates, culture plates, cell-based assays, biotech, in vitro, drug discovery, stem cells, controlled rigidity, controlled stiffness, and petri dish 35 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 4 | 6 |
 | Smart Immune Pioneering thymus-empowered T-cell platform to fight cancer and infection Smart Immune is a clinical-stage French biotechnology company developing ProTcell, a thymus-empowered T cell progenitor platform to fully and rapidly re-arm the immune system against cancer and infection, enabling next-generation allogeneic T cell therapies. The company aims to radically improve outcomes for patients in hematology and immune-oncology. Smart Immune has ongoing collaborations with leading institutions in the US and Europe. SMART101 is in Phase I/II clinical trials in cancer patients with AML and ALL, in SCID in the EU and the US. Smart Immune is also developing therapies using gene-modified T … 57 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 26 | 32 |
 | EVerZom Revolutionizing healthcare with exosomes focusing on gastrointestinal, liver and kidney regeneration EverZom is an exosome biotech company developing treatments for digestive tissue healing like Crohn's fistula and organ regeneration like the kidney and the liver. Founded in 2019, EverZom is positioned to become the leader of exosome therapeutics, the next wave of innovation for the biotech industry. Exosomes, small vesicles secreted by cells, are increasingly recognized as potent agents for intercellular communication and play a crucial role to treat a wide range of diseases. Winner of the European EIC Accelerator Program, EVerZom aims to be the upcoming pioneer in this … 2 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 13 | 18 |
 | Cilcare MAKING HEARING A PRIORITY CILCARE is a biotech dedicated to harnessing auditory sciences to reshape the future of care via early diagnosis and targeted treatment. We believe hearing acts as a valuable indicator of our health and must be monitored and preserved accordingly. As awareness of the link between hearing and chronic health conditions grows, auditory sciences are paving the way for the early detection of chronic neurocognitive, inflammatory, and age-related diseases. CILCARE External Innovation supports its partners in the health and life-sciences sector in the development of new therapies to prevent and treat auditory-related diseases including inherited hearing loss, … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 45 | 56 |
 | DeepLife AI for digital twin of cells DeepLife is an early stage startup founded in 2019 by Jonathan Baptista and Jean-Baptiste Morlot, backed by international investors, developing the first SaaS platform for Digital Twin of cells. While we are able to design and build incredibly complex mechanical engines, engineering biological systems, such as cells, remains a challenge. However, recent technological improvements, notably in biochemistry, recently enabled the construction of databases with millions of quantitative cell activity measures, covering multiple diseases. The DeepLife team develops a SaaS platform combining state-of-the-art deep learning algorithms on multi-omics sequencing data, public and private cell atlases, … 91 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Deep Learning SaaS | 22 | 29 |
 | NMR - Bio From Molecules to Medicine and Beyond NMR-Bio is a CRO located in Grenoble (France), one of the most vibrant European hubs for structural biology and supplies compounds for the selective labelling of methyl groups in perdeuterated proteins. NMR-Bio also offers a broad range of services for NMR applications: - Custom labelled protein production in bacteria, cell-free system, insect cells, HEK293 and CHO cells - Solution for labelling of your biopharmaceutics especially mAbs and Fabs - High-field NMR data acquisition and analysis (e.g. quality control, spectra assignment, structure calculation, dynamic characterisation). 59 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 2 |
 | BrainPlotting Human PK data from preclinical stages BrainPlotting is a french contract research organization company which offers his knowledge to predict the entrance of drugs into the brain To that end BrainPlotting developped in vitro models based on fresh human tissus and cells. BrainPlotting is incubated at the Brain and Spine Institute (ICM), Paris, France Our core business is the study of pharmacokinetics (PK) in the human brain. The molecules that we study can have CNS targets as well as peripheral targets. To study the brain's PK, BrainPlotting uses the most accurate predictive models and the most recent methods and tools. … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 1 |
 | Amolyt Pharma Advancing peptides for the treatment of rare endocrine and related diseases Amolyt Pharma is building on its team’s established expertise to deliver life-changing treatments to patients suffering from rare endocrine and related diseases. Amolyt Pharma’s portfolio includes eneboparatide (AZP-3601), a long-acting PTH1 receptor agonist as a potential treatment for hypoparathyroidism, and AZP-3813, a peptide growth hormone receptor antagonist for the potential treatment of acromegaly. Amolyt Pharma aims to further expand and develop its portfolio by leveraging its global network in the field of endocrinology and with support from a strong syndicate of international investors. Hypoparathyroidism, Endocrinology, Metabolic Disease, Therapeutic Peptides, … 3 similar entities Tags: FrenchTech2030 Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 12 | 38 |
 | TISSIUM Biomorphic Programmable Polymers TISSIUM was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures: to reconstruct damaged tissue and restore its natural function. Since the discovery of our first polymer at the labs of Bob Langer and Jeff Karp at MIT, we recognized the exceptional potential for our technology to revolutionize the field of tissue reconstruction in multiple therapeutic areas. Our unique approach to product development leverages the knowledge gained from the development of our technology platform comprised of proprietary polymers, activation technologies, and delivery devices. We have developed a fully … 83 similar entities Tags: FrenchTech120 Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 18 | 133 |
 | EikoSim Bridge the gap between test and simulation EikoSim is committed to help simulation teams to bridge the gap between test and model during the development phase in mechanical industries. EikoTwin users respond faster to program requests and reduce delivery time to the final customer. digital image correlation, validation, finite element analysis, identification, mechanics, testing, simulation, and VVUQ | 18 | 10 |
 | Laboratoires ERIGER Laboratoires ERIGER was acquired by Groupe Berkem. To find out more, click on the link “Visit the website”. 📍Tours 🌱New encapsulation technology through chlorophyll 🌿 Vegan, natural & sustainable 💪High concentration, protection, penetration, stability of active molecules. protection, Tailor-made, cosmetic, and pharmacy 19 similar entities Type: Startup Activities: biotech deeptech Technologies: Bio sourced materials | 11 | 9 |
 | Xegen Biostatistics & Bioinformatics company specialized in Next Generation Sequecing data analysis Xegen is a bioinformatics company specialized in Next Generation Sequencing (NGS) data analysis. We provide support for our customers or partners in their NGS data processing issues, through specific, automated, high added value bioinformatics analyzes. Xegen is developing Polypheme a bioinformatics suite dedicated to complex genes analysis (polymorphisms detection or allelic types). Polypheme analysis includes in particular HLA Typing, classic (HLA-A, -B, -C, DRB1, DQB1) and not classic genes (HLA-E, -F, -G, -H). Polypheme is also used to discover new alleles. Bioinformatics, Genomics, Typing, HLA, Diagnostics, NGS data analysis, … Type: Startup Activities: biotech deeptech Technologies: Data Analytics | 9 | 3 |
 | OREGA Biotech Discovery of novel immune checkpoint inhibitors for cancer immunotherapy OREGA Biotech specializes in the discovery and the development of first-in-class monoclonal antibodies for cancer immunotherapy. The company was incepted in 2010 and is managed by Jeremy Bastid, CEO and Gilles Alberici, President. The science at OREGA Biotech is based on the research conducted by its academic cofounders Nathalie Bonnefoy, Armand Bensussan and Jean-François Eliaou. Our in vivo screening approach aims at discovering and validating novel immune checkpoint inhibitors and regulators of anti-PD1 response. Our lead asset, an anti-CD39 monoclonal antibody, has been out-licensed to Innate (2016) Pharma and then partnered … 69 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 6 |
 | Kallistem Kallistem is a biotech company specialized in spermatogenesis. The company was founded in 2012 with the objective to anticipate and treat male infertility. It promotes a technology and expertise developed by Philippe Durand and Marie-Helene Perrard, two internationally renowned scientists in the field of the reproductive biology and more specially in in vitro spermatogenesis. Kallistem has developed, in collaboration with its partners, original and innovating technologies of germinal cell culture for male fertility preservation and the treatment of male infertility. male fertility, cellular therapy, biology of reproduction, and testicular toxicology Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 3 |
 | 4mg TRANSPARENCY Manage your core business, we manage its transparency! Manage your core business, we manage its transparency! 4MGTRANSPARENCY intervenes with the health industry (pharmaceutical, medical devices, medical visit providers, medical information delegates, health events, PSAD) and health professionals by offering a personalized, internal or outsourced management solution, regulatory and lea functions (ex DMOS) from A to Z thanks to overall support on the subject: - Audit of the internal lea management processes (ex DMOS) and transparency - Management of administrative files (Idahe, EPS) - Implementation of 4transparency, the innovative, efficient, profitable and agile digital platform that simplifies transparency (SaaS compliance management … Type: Startup Activities: healthtech biotech regtech deeptech Technologies: SaaS | 40 | 6 |
 | VETBIOLIX Vetbiolix develops innovative products for the treatment and prevention of chronic diseases affecting the chi Vetbiolix develops innovative products for the treatment and prevention of chronic diseases affecting dogs and cats. 22 similar entities Type: Startup Activities: pettech deeptech biotech healthtech | 3 | 6 |
 | X'PROCHEM We produce customised chemical proteins to help our bio-pharms partners to accelerate their projects. 🧪 X’PROCHEM is a biotech company who invented an advanced and proprietary ligation technology. We help our bio-pharma partners design and create therapeutic, vaccine and diagnostic proteins. Unlike recombinant fermentation we can produce proteins containing up to 400 amino acids, without isoforms, endotoxins, or biological contaminants. We co develop solutions with our partners to understand the real needs within the context. By working closely, we can adapt to changing needs and circumstances. protein, purification, synthesis, protein production, peptide synthesis, and life sciences 64 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 14 |
 | NEURO-SYS CNS/PNS - In vitro - In vivo - Drug Development Neuro-Sys is a research-intensive and innovative organisation specialising in pharmacology and in advanced in vitro and in vivo models of neurodegenerative diseases, mode of action research, and drug development in the CNS and PNS fields. We provide pharmacological profiles of lead compounds and explore their underlying mechanism of action and studies to determine the neuroprotective activity. We’re dedicated to providing high-level technical expertise in a collaborative relationship with our clients and accompany you along the drug development stages, from preclinical to clinical. Our expertise: › Alzheimer’s disease (AD) › Parkinson’s … 33 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 40 |
 | PhinC Development 15 years of Quantitative Pharmacology Solutions applied to the development of drug candidates. PhinC Development is the PK Modeling & Simulation partner for small to medium sized pharmaceutical or biotech companies, who need to move forward in early drug research. Based on Model-Informed Drug Development, PhinC helps you to increase the confidence in decision making and reduces cycle time of your development. Our mission consists in developing the best models to take advantage of all the research data at every phase (in vitro, in vivo animal and human) and carry out robust simulations and predictions requested and recommended by the … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 8 | 17 |
 | TransCure bioServices Leading CRO in preclinical research with cutting-edge humanized mouse models for drug development. Rethinking preclinical research - with your goals in mind. TransCure bioServices accelerates drug development by delivering the right models, the right data, with the right partnership mindset. Our advanced humanized mouse models provide robust, translational in vivo results to guide decision-making in: • Oncology (Human CDX, Human PDX, Syngeneic Models) • Inflammatory diseases (IBD, MASH, GvHD, Lung Inflammation) • Infectious diseases & toxicity (HIV, HBV, Immunotoxicity, Hepatotoxicity) You know your drug. We know how to test it. Every study is co-designed with your team to fit your … 60 similar entities Type: Startup Activities: biotech deeptech Technologies: Data Analytics | 4 | 74 |
 | Metabrain Research Twist your mind think muscle Metabrain Research is a Biopharmaceutical company developing innovation for Health Industry. We develop preventive and / or therapeutic solutions to cure pathologies linked to metabolic aging (Obesity, Diabetes, NASH, Sarcopenia, Depression and Cognitive Decline). We rely on a collaborative research technology platform combining a large number of expertise (medicinal chemistry, Biology and Pharmacology, Drug Discovery & Development, Nutraceuticals, ...). NASH, Sarcopenia, Obesity, Drug Discovery & Development, Nutraceutical, Biology & Pharmacology, Medicinal chemistry, Cognitive decline, Diabetes, Research&Development, Aging, CRO, Vitro-Vivo models, Active Aging, Metabolic Disorders, Muscle, IA, Cardiorenal disease, and Artificial intelligence 33 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. | 0 | 4 |
 | Biocellvia Biocellvia evaluates the efficacy of your lead molecules from histological slides thanks to our digital technology Biocellvia is a french digital pathology company developing Intelligent Image Analysis solutions for pharmaceutical industry (Big Pharma, Biotechs, CRO) and academic communities involved in R&D. We have developed digital image analysis solutions, that enable to evaluate fully-automatically the level of efficacy of your lead molecules thanks to histological slides (in vitro, ex vivo, biopsies) in various pathologies such as: - Gastrointestinal (NASH, Liver fibrosis) - Respiratory (IPF, COPD, PAH) We provide image analysis as a service. Our technology evaluates your molecules with more accuracy, … Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Image Processing | 8 | 6 |
 | Stimunity Turn cancer immunotherapies active in most patient Stimunity is a startup company from Institut Curie which develops bio-pharmaceuticals to treat patients that do not respond to immunotherapy in cancer. 25 similar entities Type: Startup Activities: biotech deeptech | 3 | 5 |
 | IXICO Experts in end-to-end management and analysis of neuroimaging clinical trials powered by expertise & AI. Advancing medicine and human health by transforming data into clinically meaningful insights. IXICO is a premier neuroimaging provider helping biopharmaceutical companies maximize the value of their drug development pipelines by transforming data into clinically meaningful insights. Bringing together world-class therapeutic expertise, breakthrough analytics and operational excellence, IXICO is the proven partner of choice for imaging biomarker solutions in CNS clinical trials. Medical imaging, Clinical Trials, Alzheimer's Disease, Clinical Decision Support, Parkinson's Disease, Multiple Sclerosis, Progressive Supranuclear Palsy, Huntington's Disease, Cerebrovascular Disease, Digital Biomarkers, Neuroimaging, AI-driven … 13 similar entities Type: SMB Activities: deeptech biotech healthtech Technologies: A.I. Data Analytics | 0 | 83 |
 | OM Pharma Transforming Immune Health We use our expertise in bacterial lysates to address the world’s most significant health challenges from the rise in infectious disease outbreaks to antimicrobial resistance. Currently active in the prevention of respiratory and urinary tract infections, our constantly evolving understanding of how bacterial lysates interact with the immune system motivates us to invest in new indications and new formulations for our lysates. Headquartered in Geneva with affiliates in Peru and Switzerland, our products are available in more than 100 countries through a network of trusted partners. Infectious diseases, Vascular diseases, and immunological imbalances Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech biotech | 1 | 588 |
 | III-V Lab III-V Lab is a private R&D organisation jointly established by Nokia, Thales and the CEA under the French “Economic Interest Grouping” (GIE) status. III-V Lab concentrates in a single entity the most advanced industrial research capabilities in the field of III-V semiconductors in Europe. Such structure has enabled the rapid development of a common platform for dual use opto- and micro-electronic technology; it has been considered that both partners have brought balanced efforts, skills, equipment and background IPs, so that the costs of this common laboratory may be equally shared. III-V lab offers pre-commercial and customized production of III-V components … Type: SMB Activities: deeptech biotech Technologies: Semiconductors | 6 | 55 |
 | MEDIPATH FRANCE Proximity diagnosis and expertise in cancerology Leader in France, Medipath is a reference player nationally in the screening and diagnosis of pathologies, particularly in cancerology. With more than 25 years of expertise, Medipath continues his public health mission by maintaining a reinforced proximity with his clinicians. Liberal company, governed by the pathologists who compose it, our desire remains unchanged: maintaining a high level of expertise and quality and engaging daily in the fight against cancer by offering leading services. Medipath has more than 120 doctors, 12 doctors pathologists referents in the national expertise networks of rare pathologies of the National … Type: SMB Activities: healthtech deeptech biotech Technologies: SaaS | 16 | 381 |
 | AYOXXA Biosystems GmbH AYOXXA – the Translational Proteomics Company. Understanding complex biology from bench to bedside. AYOXXA - The translational proteomics company AYOXXA Biosystems GmbH, based in Cologne (Germany), is an international biotech company focused on the development of its proprietary beads-on-a-chip technology for advanced protein analysis. LUNARISTM. AYOXXA’s innovative multiplex protein analysis platform is a fully integrated system designed for the parallel analysis of multiple biomarkers in picogram amounts of biological samples, allowing scientists to gain a maximum of high quality and reproducible insights. LUNARISTM is fully scalable, with integrated, image-based quality control and transparent data processing and management, enabling translational proteomics … 12 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 23 |
 | Cearitis Biocontrol and innovation for the protection of your crops. CEARITIS supports you in the protection of your tree crops thanks to biocontrol and agroecology. 🌿 We offer a Biocontrol system for protection against tree pests. Inspired by what already exists in nature, this solution mimics the interactions between the tree and the pest. Composed of an attractant and a repellent, this autonomous system protects up to 90% of your crops. 🌿 We offer an agroecology support service that allows sustainable management of natural resources for autonomy and sustainability of orchards. By working on the design of the production space and … 14 similar entities Type: Startup Activities: biotech Technologies: Bio sourced materials | 30 | 19 |
 | LPS-BioSciences Improving Vaccines, Diagnostics and Medical Devices With Endotoxins Expertise. LPS-Biosciences is an innovative SME in biotechnology, founded in November 2011. SAS with a capital of € 50,000. LPS-Biosciences offers companies of human and animal health, cosmetics and agrifood services and endotoxins (LPS) analysis and extraction services, molecules present on the surface of bacteria and playing a major role in the immune reaction. The company also carries out collaboration projects in the fields of bacterial detection (E. coli, Erwinia) The company's flagship project lies in the search for a new vaccine adjuvant, based on LPS, for which LPS-Biosciences received the support … 6 similar entities Type: Startup Activities: biotech healthtech agritech deeptech Technologies: Data Analytics | 4 | 12 |
 | Lycored Cultivating wellnessTM Nutrition isn’t complicated. For us, it’s natural. We’ve been a leader in the research and development of carotenoid-based products for the last two decades and we take that role very seriously. This means we approach everything we do with a sense of wonder and a driving desire to find the best possible outcome or create the highest-quality product. Sometimes we begin with an actual seed (from one of our tomato farms) and sometimes we start with the seed of an idea—maybe a health-related concern or even a question that was posed by one of our scientists on a … Type: SMB Activities: healthtech biotech Technologies: Bio sourced materials | 0 | 168 |